学科分类
/ 10
190个结果
  • 简介:Despitethehnpactofhighly-activemltiretroviraltherapy(HAART),manifestedasmarkedreductionsintheincidenceofopwrtunistieinfectionsinthelast5,years,respiratoryproblemsstillconstituteamajorburdenofdiseaseinthoseinfectedwithHIV.ReasonsforthisincludethelimitedavailabilityofHAART.worldwide,thefailureofsustainedviralsuppressioninupto50%ofpatientstakingHAART,failureofprophylaxisforspecificopportunisticinfectiorrs,andanincreasingnumberofpatientspresentingwithpreviouslymldiagnosedadvancedHIVinfection.

  • 标签:AIDS强效抗反转录病毒治疗HIV感染细菌性肺炎卡式肺囊虫性肺炎结核病
  • 简介:

  • 标签:
  • 简介:AbstractPurpose:To establish a severe blastlunginjury model of goats and investigate the feasibility oflungultrasonic score in the evaluation of blastlunginjury.Methods:Twenty female healthy goats were randomly divided into three groups by different driving pressures: 4.0 MPa group (n = 4), 4.5 MPa group (n = 12) and 5.0 MPa group (n = 4). The severe blastlunginjury model of goats was established using a BST-I bio-shock tube. Vital signs (respiration, heart rate and blood pressure),lungultrasound score (LUS), PO2/FiO2 and extravascularlungwater (EVLW) were measured before injury (0 h) and at 0.5 h, 3 h, 6 h, 9 h, 12 h after injury. Computed tomography scan was performed before injury (0 h) and at 12 h after injury for dynamic monitoring of blastlunginjury and measurement oflungvolume. The correlation of LUS with PaO2/FiO2, EVLW, andlunginjury ratio (lesion volume/totallungvolume*100%) was analyzed. All animals were sacrificed at 12 h after injury for gross observation oflunginjury and histopathological examination. Statistical analysis was performed by the SPSS 22.0 software. The measurement data were expressed as mean ± standard deviation. The means of two samples were compared using independent-sample t-test. Pearson correlation analysis was conducted.Results:(1) At 12 h after injury, the mortality of goats was 0, 41.67% and 100% in the 4.0 Mpa, 4.5 MPa and 5.0 MPa groups, respectively; the area of pulmonary hemorrhage was 20.00% ± 13.14% in the 4.0 Mpa group and 42.14% ± 15.33% in the 4.5 MPa group. A severelungshock injury model was established under the driving pressure of 4.5 MPa. (2) The respiratory rate, heart rate, LUS and EVLW were significantly increased, while PaO2/FiO2 was significantly reduced immediately after injury, and then they gradually recovered and became stabilized at 3 h after injury. (3) LUS was positively correlated with EVLW (3 h: r = 0.597, 6 h: r = 0.698, 9 h: r = 0.729; p < 0.05) andlunginjury ratio (12 h: r= 0.884, p < 0.05), negatively correlated with PaO2/FiO2 (3 h: r =-0.871, 6 h: r =-0.637, 9 h: r =-0.658; p < 0.05).Conclusion:We established a severe blastlunginjury model of goats using the BST-I bio-shock tube under the driving pressure of 4.5 MPa and confirmed that ultrasound can be used for quick evaluation and dynamic monitoring of blastlunginjury.

  • 标签:Blast injuriesLung injuryGoatsBio-shock tube
  • 简介:Objective:Variousnanoparticleshavebeendesignedandtestedinordertoselectoptimalcarriersfortheinhalationdeliveryofanticancerdrugstothelungs.Methods:Thefollowingnanocarrierswerestudied:micelles,liposomes,mesoporoussilicananoparticles(MSNs),polypropyleneimine(PPI)dendrimer-siRNAcomplexesnanoparticles,quantumdots(QDs),andpoly(ethyleneglycol)polymers.Allparticleswerecharacterizedusingthefollowingmethods:dynamiclightscattering,zetapotential,atomicforcemicroscopy,invitrocyto-andgenotoxicity.Invivoorgandistributionofallnanoparticles,retentioninthelungs,andanticancereffectsofliposomesloadedwithdoxorubicinwereexaminedinnudemiceafterthepulmonaryorintravenousdelivery.Results:Significantdifferencesinlunguptakewerefoundaftertheinhalationdeliveryoflipid-basedandnon-lipid-basednanoparticles.Theaccumulationofliposomesandmicellesinlungsremainedrelativelyhigheven24hafterinhalationwhencomparedwithMSNs,QDs,andPPIdendrimers.Therewerenotabledifferencesbetweennanoparticleaccumulationinthelungsandotherorgans1and3hafterinhalationorintravenousadministrations,but24hafterintravenousinjectionallnanoparticlesweremainlyaccumulatedintheliver,kidneys,andspleen.Inhalationdeliveryofdoxorubicinbyliposomessignificantlyenhanceditsanticancereffectandpreventedsevereadversesideeffectsofthetreatmentinmicebearingtheorthotopicmodeloflungcancer.Conclusion:Theresultsofthestudydemonstratethatlipid-basednanocarriershadconsiderablyhigheraccumulationandlongerretentiontimeinthelungswhencomparedwithnon-lipid-basedcarriersaftertheinhalationdelivery.Theseparticlesaremostsuitableforeffectiveinhalationtreatmentoflungcancer.

  • 标签:纳米载体肺部肺癌治疗积聚硅纳米颗粒
  • 简介:AbstractThis review attempts to unveil the possible mechanisms underlying how gut lymph affectslungand further gives rise to acute respiratory distress syndrome, as well as potential interventional targets under the condition of ischemia-reperfusion injury. We searched electronic databases including PubMed, MEDLINE, Cochrane Central Register of Controlled Trials, Google Scholar, Web of Science, and Embase to identify relevant literatures published up to December 2019. We enrolled the literatures including the Mesh Terms of "gut lymph or intestinal lymph and acutelunginjury or acute respiratory distress syndrome." Gut is considered to be the origin of systemic inflammation and the engine of multiple organ distress syndrome in the field of critical care medicine, whereas gut lymph plays a pivotal role in initiation of ischemia-reperfusion injury-induced acute respiratory distress syndrome. In fact, in the having been established pathologic model of sepsis leading to multiple organ dysfunction named by Gut Lymph theory, a variety of literatures showed the position and role of changes in gut lymph components in the initiation of systemic inflammatory response, which allows us to screen out potential intervention targets to pave the way for future clinic and basic research.

  • 标签:Gut lymphIschemia-reperfusion injuryAcute respiratory distress syndromeMultiple organ dysfunction syndrome
  • 简介:AbstractExtracellular vesicles (EVs) are anuclear particles composed of lipid bilayers that contain nucleic acids, proteins, lipids, and organelles. EVs act as an important mediator of cell-to-cell communication by transmitting biological signals or components, including lipids, proteins, messenger RNAs, DNA, microRNAs, organelles, etc, to nearby or distant target cells to activate and regulate the function and phenotype of target cells. Under physiological conditions, EVs play an essential role in maintaining the homeostasis of the pulmonary milieu but they can also be involved in promoting the pathogenesis and progression of various respiratory diseases including chronic obstructive pulmonary disease, asthma, acutelunginjury/acute respiratory distress syndrome, idiopathic pulmonary fibrosis (IPF), and pulmonary artery hypertension. In addition, in multiple preclinical studies, EVs derived from mesenchymal stem cells (EVs) have shown promising therapeutic effects on reducing and repairinglunginjuries. Furthermore, in recent years, researchers have explored different methods for modifying EVs or enhancing EVs-mediated drug delivery to produce more targeted and beneficial effects. This article will review the characteristics and biogenesis of EVs and their role inlunghomeostasis and various acute and chroniclungdiseases and the potential therapeutic application of EVs in the field of clinical medicine.

  • 标签:Lung diseasesBiomarkerLung disease pathogenesisExtracellular vesiclesClinical application
  • 简介:Differentapproachesfortreatinglungcancerhavebeendevelopedovertime,includingchemotherapy,radiotherapyandtargetedtherapiesagainstactivatingmutations.Lately,betterunderstandingoftheroleoftheimmunologicalsystemintumorcontrolhasopenedmultipledoorstoimplementdifferentstrategiestoenhanceimmuneresponseagainstcancercells.Itisknownthattumorcellseludeimmuneresponsebyseveralmechanisms.Thedevelopmentofmonoclonalantibodiesagainstthecheckpointinhibitorprogrammedcelldeathprotein1(PD-1)anditsligand(PD-L1),onTcells,hasledtohighactivityincancerpatientswithlonglastingresponses.Nivolumab,anantiPD-1inhibitor,hasbeenrecentlyapprovedforthetreatmentofsquamouscelllungcancerpatients,giventhesurvivaladvantagedemonstratedinaphaseIIItrial.Pembrolizumab,anotherantiPD-1antibody,hasreceivedFDAbreakthroughtherapydesignationfortreatmentofnon-smallcelllungcancer(NSCLC),supportedbydatafromaphaseItrial.ClinicaltrialswithantiPD-1/PD-L1antibodiesinNSCLChavedemonstratedverygoodtolerabilityandactivity,withresponseratesaround20%andamediandurationofresponseof18months.

  • 标签:非小细胞肺癌免疫治疗单克隆抗体程序性细胞死亡肿瘤细胞临床试验
  • 简介:

  • 标签:
  • 简介:AbstractImmunotherapy has become the mainstay forlungcancer treatment, providing sustained therapeutic responses and improved prognosis compared with those obtained with surgery, chemotherapy, radiotherapy, and targeted therapy. It has the potential for anti-tumor treatment and killing tumor cells by activating human immunity and has moved the targets of anti-cancer therapy from malignant tumor cells to immune cell subsets. Two kinds of immune checkpoints, cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed death-1 (PD-1)/programmed death ligand 1 (PD-L1), are the main targets of current immunotherapy inlungcancer. Despite the successful outcomes achieved by immune checkpoint inhibitors, a small portion oflungcancer patients remain unresponsive to checkpoint immunotherapy or may ultimately become resistant to these agents as a result of the complex immune modulatory network in the tumor microenvironment. Therefore, it is imperative to exploit novel immunotherapy targets to further expand the proportion of patients benefiting from immunotherapy. This review summarizes the molecular features, biological function, and clinical significance of several novel checkpoints that have important roles inlungcancer immune responses beyond the CTLA-4 and PD-1/PD-L1 axes, including the markers of co-inhibitory and co-stimulatory T lymphocyte pathways and inhibitory markers of macrophages and natural killer cells.

  • 标签:Lung cancerImmunotherapyTargets
  • 简介:肺上皮是在各种各样的肺疾病的肺损坏的主要地点。上皮的房间apoptosis被认为是在各种各样的肺疾病的起始的事件。发信号的Apoptosis古典主义地由二条原则小径组成。一个人是从死亡受体结扎的一条直接小径到caspase串联激活和房间死亡。象药,放射,传染代理人和反应的氧种类那样的压力触发的另外的小径被线粒体调停。Endoplasmic蜂窝胃也被显示了是细胞器调停apoptosis.Epithelial房间死亡被改变过程跟随,它由组成上皮并且成纤维细胞激活,cytokine生产,凝结小径的激活,neoangiogenesis,re-epithelialization和fibrosis.Epithelial和间充质的相互作用在这些过程起重要作用。apoptosis由新奇策略发信号和它的规定的进一步的理解可以对各种各样的肺疾病导致有效治疗。我们在apoptosis发信号的理解考察最近的进展并且在肺改变讨论apoptosis的参与。

  • 标签:肺损伤肺纤维化细胞凋亡COPD
  • 简介:FromNovember1,2013,TranslationalLungCancerResearch(TLCR)isofficiallyendorsedbytheSpanishLungCancerGroup(Figure1).ThisisameaningfulmilestoneforTLCRasanacknowledgmentofitsexpansionanddedicationtolungcancerresearchandwilltremendouslyadvanceitscontinuedexplorationinthefield.SinceitwaslaunchedinMay2013,TLCRhasbeendedicatedtoprovidingcutting-edgefindingsintherapidly

  • 标签:西班牙肺癌学术合作视野
  • 简介:AIM:TopreparepolylacticacidmicrospheresofErythromycinforLungtargeting.METHEDS:Theorthogonaltestdesignwasusedtooptimizethetechnology,ofpreparation.Thecharacterofthemicrospheres,drugreleaseinvitro,stabilityandtissuedistributionwereexaminedRESULTS:TheErythromycinpolylacticacidmicrosphereswasregularinitsmorphology.DrugwasenvelopedinmicrospheresbutnotphysicallymixedwithPDLLA.Theaverageparticlesizewas11.65μnwithover94%ofthemicrospheresbeingintherangeof5~20trn;Thedrugloadingandtheincorporationefciencywere18%and60%respectively.Themicrosphereswerestableforthreemonthat4℃androomtemperature.TheinvitroreleasepropertiescouldbeexpressedbytheHiguchi'sequation:y=28.067+3.8515t11/2(r=0.9834).Comparingwithinjection,thedruginmicrosphereswasmoreconcentratedinlungtissue.CONCLUSION:Erythromycinpolylacticacidmicrospheresshowedsignificantsustainedreleaseandlungtargeting.

  • 标签:红霉素聚乳酸微球粒肺目标命中
  • 简介:LyingatthesouthernfootofMountJishiinJishishanCountyborderingGansuandQinghaiProvinces,Hor-sTag-lungMonastery(thereafterabbreviatedtosTag-lungMonastery)isawell-knownTibetanBuddhistmonasterybuiltintheearlyperiodofTibetanBuddhism.Ithasahistoryofmorethan400yearsandwasaffiliatedwithbKra-shis-lhun-poMonastery.Its

  • 标签:西藏基督教修道院宗教信仰
  • 简介:AbstractBackground:Acute kidney injury (AKI) is a common and serious complication followinglungtransplantation (LTx), and it is associated with high mortality and morbidity. This study assessed the incidence of AKI after LTx and analyzed the associated perioperative factors and clinical outcomes.Methods:This retrospective study included all adult LTx recipients at the China-Japan Friendship Hospital in Beijing between March 2017 and December 2019. The outcomes were AKI incidence, risk factors, mortality, and kidney recovery. Multivariate analysis was performed to identify independent risk factors. Survival analysis was presented using the Kaplan-Meier curves.Results:AKI occurred in 137 of the 191 patients (71.7%), with transient AKI in 43 (22.5%) and persistent AKI in 94 (49.2%). AKI stage 1 occurred in 27/191 (14.1%), stage 2 in 46/191 (24.1%), and stage 3 in 64/191 (33.5%) of the AKI patients. Renal replacement therapy (RRT) was administered to 35/191 (18.3%) of the patients. Male sex, older age, mechanical ventilation (MV), severe hypotension, septic shock, multiple organ dysfunction (MODS), prolonged extracorporeal membrane oxygenation (ECMO), reintubation, and nephrotoxic agents were associated with AKI (P < 0.050). Persistent AKI was independently associated with preoperative pulmonary hypertension, severe hypotension, post-operative MODS, and nephrotoxic agents. Severe hypotension, septic shock, MODS, reintubation, prolonged MV, and ECMO during or after LTx were related to severe AKI (stage 3) (P < 0.050). Patients with persistent and severe AKI had a significantly longer duration of MV, longer duration in the intensive care unit (ICU), worse downstream kidney function, and reduced survival (P < 0.050).Conclusions:AKI is common after LTx, but the pathogenic mechanism of AKI is complicated, and prerenal causes are important. Persistent and severe AKI were associated with poor short- and long-term kidney function and reduced survival in LTx patients.

  • 标签:Acute kidney injuryAdult lung transplantationIncidenceOutcomesRisk factors
  • 简介:AbstractLung cancer continues to be the leading cause of cancer-related death in the world, which is classically subgrouped into two major histological types: Non-small celllungcancer (NSCLC) (85% of patients) and small-celllungcancer (SCLC) (15%). Tumor location has been reported to be associated with the prognosis of various solid tumors. Several types of cancer often occur in a specific region and are more prone to spread to predilection locations, including colorectal cancer, prostate cancer, gastric cancer, ovarian cancer, cervical cancer, bladder cancer,lungtumor, and so on. Besides, tumor location is also considered as a risk factor forlungneoplasm with chronic obstructive pulmonary disease/emphysema. Additionally, the primarylungcancer location is associated with specific lymph node metastasis. And the recent analysis has shown that the primary location may affect metastasis pattern in metastatic NSCLC based on a large population. Numerous studies have enrolled the "location" factor in the risk model. Anatomy location and lobe-specific location are both important in prognosis. Therefore, it is important for us to clarify the characteristics about tumor location according to various definitions. However, the inconsistent definitions about tumor location among different articles are controversial. It is also a significant guidance in multimode therapy in the present time. In this review, we mainly aim to provide a new insight about tumor location, including anatomy, clinicopathology, and prognosis in patients withlungneoplasm.

  • 标签:Lung neoplasmsNon-small cell lung cancerSmall-cell lung cancerLocationMain bronchusNon-main bronchusClinicopathological
  • 简介:

  • 标签:
  • 简介:

  • 标签:
  • 简介:Immunotherapyhasbecomeakeystrategyforcancertreatment,andtwoimmunecheckpoints,namely,programmedcelldeath1(PD-1)anditsligand(PD-L1),haverecentlyemergedasimportanttargets.TheinteractionblockadeofPD-1andPD-L1demonstratedpromisingactivityandantitumorefficacyinearlyphaseclinicaltrialsforadvancedsolidtumorssuchasnon-smallcelllungcancer(NSCLC).ManycelltypesinmultipletissuesexpressPD-L1aswellasseveraltumortypes,therebysuggestingthattheligandmayplayimportantrolesininhibitingimmuneresponsesthroughoutthebody.Therefore,PD-L1isacriticalimmunomodulatingcomponentwithinthelungmicroenvironment,butthecorrelationbetweenPD-L1expressionandprognosisiscontroversial.MoreevidenceisrequiredtosupporttheuseofPD-L1asapotentialpredictivebiomarker.ClinicaltrialshavemeasuredPD-L1intumortissuesbyimmunohistochemistry(IHC)withdifferentantibodies,buttheassessmentofPD-L1isnotyetstandardized.Somecommercialantibodieslackspecificityandtheirreproducibilityhasnotbeenfullyevaluated.FurtherstudiesarerequiredtoclarifytheoptimalIHCassayaswellastopredictandmonitortheimmuneresponsesofthePD-1/PD-L1pathway.

  • 标签:非小细胞肺癌免疫治疗免疫反应预测监测程序性细胞死亡
Baidu
map